Details for 2014824108

Up to date per 03.04.2026

Actions

Title / Product Name

KRISTALLINE SALZFORM VON (S)-(2-(6-CHLOR-7-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1-YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANON ALS OREXIN-REZEPTOR-ANTAGONISTEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014824108

EP Publication Number

3077390

E-Number

928005

Language

PCT Number

IB14066509

Publication Date

12.10.2016 A

13.09.2017 B1

Registration Date

13.09.2017

AT Publication Date

15.10.2017

Application Date

02.12.2014

Registration Number

Priorities

03.12.2013

PCT/IB2013/060595

IPC

C07D 403/14 20060101AFI20150619BHEP

Maximum Duration of Protection

02.12.2034

Owner

Idorsia Pharmaceuticals LtdHegenheimermattweg 91 4123 AllschwilCH

Representative

DR. MÜLLNER DIPL.-ING. KATSCHINKA OG, PATENTANWALTSKANZLEIWeiburggasse 91014 WIENAT

Inventor

BOSS, Christophc/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 CH-4123 AllschwilCH

BROTSCHI, Christinec/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 CH-4123 AllschwilCH

GUDE, MarkusGrabenring 9 CH-4123 AllschwilCH

HEIDMANN, Bibiac/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 CH-4123 AllschwilCH

SIFFERLEN, Thierryc/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 CH-4123 AllschwilCH

VON RAUMER, Markusc/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 CH-4123 AllschwilCH

WILLIAMS, Jodi T.c/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 CH-4123 AllschwilCH

Information about Fees